JACC. Asia · 2025
Epidemiology of Valvular Heart Disease in Asia Pacific Region.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
So Kent Chak-Yu, Yap Jonathan, Song Guang-Yuan, Poon Karl, Sung Shih-Hsien, Chandavimol Mann, Hayashida Kentaro, Park Duk-Woo, Ewe See-Hooi, Chen Mi, Hei-Tung Chan Vyanne, Iwata Juri, Tangcharoen Tarinee, Tern Paul, Park Han-Su, Alasnag Mirvat, Ohno Yohei, Hon Jimmy Kim Fatt, Bhagwandeen Rohan, Tabata Minoru, Lee Alex Pui-Wai, Jilaihawi Hasan, Wang Dee Dee, Tang Gilbert H L, Lim D Scott, Modine Thomas, Lam Yat-Yin
Аннотация
Valvular heart disease poses a significant health burden in the Asia-Pacific region, with its epidemiology varying widely across countries caused by diverse socioeconomic and health care situations. Rheumatic heart disease remains prevalent, especially in low- to middle-income areas, while degenerative valvular diseases are emerging in developed regions caused by an aging population. Significant disparities in access to health care and intervention result in variable clinical outcomes. In the past decade, transcatheter interventions have revolutionized the management of patients with valvular heart disease globally. In the Asia-Pacific region, the uptake and development of transcatheter valvular interventions has been slow until recent years. Continued collaboration across the Asia-Pacific region is essential to mitigate the impact of the upcoming surge of valvular heart disease in this diverse and rapidly changing area.